Guidelines for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic

June 23, 2021

Lana Dykes

Lana Dykes

Lana Dykes is the editor of Rheumatology Network. She is an accomplished editor and technical writer with a proven history of working in the banking and publishing industry. She likes cooking, yoga and drawing.

The American College of Rheumatology has updated its treatment guidelines for treating pediatric rheumatic disease during the COVID-19 pandemic. The guideline contains 33 final recommendations for guidance, of which 8 have received moderate to high consensus from the task force.

The American College of Rheumatology has updated its treatment guidelines for treating pediatric rheumatic disease (PRD) during the COVID-19 pandemic. The guideline contains 33 final recommendations for guidance, of which 8 have received moderate to high consensus from the task force. They discuss the importance of preventive measures, telemedicine practices and continuing a vaccination schedule for children.

“This guidance is presented as a ‘living document’, recognizing that the literature on COVID-19 is evolving rapidly, with future updates expected,” researchers said.

In this slideshow we highlight the 8 strongest recommendations.

Related content:

Comments are closed.